Literature DB >> 23065534

Telomeres and tissue engineering: the potential roles of TERT in VEGF-mediated angiogenesis.

Fernando P Hartwig1, Fernanda Nedel, Tiago V Collares, Sandra B C Tarquinio, Jacques E Nör, Flávio F Demarco.   

Abstract

Telomeres are protective structures located at the end of eukaryotic chromosomes which are shortened after each cell division, leading to senescence. Telomerase activity prevents telomere shortening by reverse transcription catalyzed by the subunit called TERT (telomerase reverse transcriptase). TERT expression has shown interesting cellular properties, which may be appealing for tissue engineering, such as the enhancement of cell proliferation and differentiation abilities in vitro. Despite some evidence for playing these roles in VEGF (vascular endothelial growth factor)-mediated angiogenesis, it is still unclear whether TERT can contribute to this essential event to generate functional organs. This review suggests a hypothesis that TERT and VEGF potentially regulates the transcriptional expression of each other, which would give new perspectives in the roles of telomerase in regulating several cellular processes, and also contributing for a better comprehension of the molecular mechanisms underlying VEGF signaling (both paracrine and autocrine). In general, based on the literature revised, it is possible to conclude that TERT is a potential VEGF enhancer; however, it is necessary to elaborate methodological approaches to explore this potential and to assess the potential benefits on tissue engineering approaches.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23065534     DOI: 10.1007/s12015-012-9414-3

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   5.739


  68 in total

Review 1.  The two-stage mechanism controlling cellular senescence and immortalization.

Authors:  W E Wright; J W Shay
Journal:  Exp Gerontol       Date:  1992 Jul-Aug       Impact factor: 4.032

Review 2.  Is endothelium the origin of endothelial progenitor cells?

Authors:  Mervin C Yoder
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-05-07       Impact factor: 8.311

Review 3.  Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins.

Authors:  Paula Martínez; María A Blasco
Journal:  Nat Rev Cancer       Date:  2011-03       Impact factor: 60.716

4.  Telomerase activity in human germline and embryonic tissues and cells.

Authors:  W E Wright; M A Piatyszek; W E Rainey; W Byrd; J W Shay
Journal:  Dev Genet       Date:  1996

5.  Recombinant adenovirus-mediated human telomerase reverse transcriptase gene can stimulate cell proliferation and maintain primitive characteristics in bovine mammary gland epithelial cells.

Authors:  Xiao-Ying He; Yue-Mao Zheng; Jie Lan; Yue-Hong Wu; Jing Yan; Xiao-Ning He; Tuo Zhang; Yu-Long He; Yan-Ling Zheng; Yong Zhang
Journal:  Dev Growth Differ       Date:  2011-03-30       Impact factor: 2.053

6.  Effects of telomerase and telomere length on epidermal stem cell behavior.

Authors:  Ignacio Flores; María L Cayuela; María A Blasco
Journal:  Science       Date:  2005-07-21       Impact factor: 47.728

7.  Whole chromosome loss is promoted by telomere dysfunction in primary cells.

Authors:  Judit Pampalona; David Soler; Anna Genescà; Laura Tusell
Journal:  Genes Chromosomes Cancer       Date:  2010-04       Impact factor: 5.006

8.  Telomeres shorten during ageing of human fibroblasts.

Authors:  C B Harley; A B Futcher; C W Greider
Journal:  Nature       Date:  1990-05-31       Impact factor: 49.962

9.  Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing.

Authors:  Kwok-Kin Wong; Richard S Maser; Robert M Bachoo; Jayant Menon; Daniel R Carrasco; Yansong Gu; Frederick W Alt; Ronald A DePinho
Journal:  Nature       Date:  2003-01-22       Impact factor: 49.962

10.  Telomerase reverse transcriptase activates the expression of vascular endothelial growth factor independent of telomerase activity.

Authors:  Lili Zhou; Danhua Zheng; Miao Wang; Yu-Sheng Cong
Journal:  Biochem Biophys Res Commun       Date:  2009-06-25       Impact factor: 3.575

View more
  7 in total

Review 1.  Up-regulating telomerase and tumor suppressors: focusing on anti-aging interventions at the population level.

Authors:  Fernando Pires Hartwig; Daniel Bertoldi; Martin Larangeira; Mônica Silveira Wagner
Journal:  Aging Dis       Date:  2013-10-08       Impact factor: 6.745

Review 2.  Efficacy and safety of bevacizumab in progressive pediatric low-grade glioma: a systematic review and meta-analysis of outcome rates.

Authors:  Victor M Lu; John P Welby; Cody L Nesvick; David J Daniels
Journal:  Neurooncol Pract       Date:  2020-02-03

3.  Telomere length and hTERT in mania and subsequent remission.

Authors:  Rugül Köse Çinar
Journal:  Braz J Psychiatry       Date:  2017-07-06       Impact factor: 2.697

4.  Preparation, modification, and characterization of alginate hydrogel with nano-/microfibers: a new perspective for tissue engineering.

Authors:  Bianca Palma Santana; Fernanda Nedel; Evandro Piva; Rodrigo Varella de Carvalho; Flávio Fernando Demarco; Neftali Lenin Villarreal Carreño
Journal:  Biomed Res Int       Date:  2013-06-05       Impact factor: 3.411

5.  Long-term lithium treatment in bipolar disorder is associated with longer leukocyte telomeres.

Authors:  L Martinsson; Y Wei; D Xu; P A Melas; A A Mathé; M Schalling; C Lavebratt; L Backlund
Journal:  Transl Psychiatry       Date:  2013-05-21       Impact factor: 6.222

Review 6.  Therapeutic Targeting of Telomerase.

Authors:  Kathrin Jäger; Michael Walter
Journal:  Genes (Basel)       Date:  2016-07-21       Impact factor: 4.096

7.  Treatment of diabetes mellitus-induced erectile dysfunction using endothelial progenitor cells genetically modified with human telomerase reverse transcriptase.

Authors:  Yan Zhang; Zhi Chen; Tao Wang; Jun Yang; Rui Li; Shaogang Wang; Jihong Liu; Zhangqun Ye
Journal:  Oncotarget       Date:  2016-06-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.